Medacta Group (FRA:6MD) Forward Dividend Yield %: 0.85% (As of Jun. 25, 2026)


FRA:6MD Medacta Group SA FRA:6MD
91 GF Score
Price €143.00
GF Value €178.79
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medacta Group Forward Dividend Yield %?

Medacta Group FRA:6MD +1.42% 91 Forward Dividend Yield % is 0.85% as of Jun. 25, 2026. GuruFocus rates FRA:6MD with a GF Score™ of 91/100 and a GF Value™ of €178.79 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Medacta Group ranks worse than 81.33% on this metric.

As of today (2026-06-25), the Forward Annual Dividend Yield of Medacta Group is 0.85%.

As of today (2026-06-25), the Trailing Annual Dividend Yield of Medacta Group is 0.85%.

FRA:6MD's Forward Dividend Yield % is ranked worse than
81.33% of 316 companies
in the Medical Devices & Instruments industry
Industry Median: 2.045 vs FRA:6MD: 0.85

Medacta Group's Dividends per Share for the six months ended in Dec. 2025 was €0.00.

During the past 12 months, Medacta Group's average Dividends Per Share Growth Rate was 31.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 10.50% per year.

During the past 11 years, the highest 3-Year average Dividends Per Share Growth Rate of Medacta Group was 10.50% per year. The lowest was 10.50% per year. And the median was 10.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Medacta Group  (FRA:6MD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Medacta Group Forward Dividend Yield % Related Terms


FRA:6MD vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Medacta Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Medacta Group's Forward Dividend Yield % falls into.


FRA:6MD
91GF Score
Medacta Group SA FRA:6MD
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medacta Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Medacta Group Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CHF 1.1000002026-05-072026-05-082026-05-11Cash DividendannuallyCHF:EUR 1.092791

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Medacta Group's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=1.2020701/143.00
=0.84 %

Current Share Price is €143.00.
Medacta Group's Dividends per Share for the forward twelve months is calculated as €1.2020701 * 1 = €1.2020701.

Medacta Group's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=1.2020701/143.00
=0.84 %

Current Share Price is €143.00.
Medacta Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is €1.2020701.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.85% mean?
Medacta Group (FRA:6MD) has a Forward Dividend Yield % of 0.85% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medacta Group and its competitors. According to the industry distribution chart, Medacta Group ranks #257 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 81.3%.
Is Medacta Group's Forward Dividend Yield % too high?
Medacta Group's current Forward Dividend Yield % is 0.85%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.05. Medacta Group's value of 0.85% is 58.4% below this industry median. Based on the distribution chart, Medacta Group ranks #257 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medacta Group has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #257 out of 316 companies for Forward Dividend Yield %. This places Medacta Group in the lower half of its industry. The industry median Forward Dividend Yield % is 2.05. Medacta Group's value of 0.85% is 58.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.05, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medacta Group's current Forward Dividend Yield % of 0.85% is 58.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medacta Group and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medacta Group's current Forward Dividend Yield % is 0.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Based on GuruFocus' analysis, Medacta Group (FRA:6MD) is currently considered Modestly Undervalued. The stock's GF Value™ is €178.79, compared to a current price of €143.00 — trading 20% below its estimated fair value. The current Forward Dividend Yield % is 0.85% and 58.4% below the Medical Devices & Instruments industry median of 2.05. Medacta Group's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Medacta Group (FRA:6MD), the current Forward Dividend Yield % is 0.85% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medacta Group (FRA:6MD) Overvalued in 2026?

Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued. The current stock price of €143.00 is trading 20% below its estimated GF Value™ of €178.79. GuruFocus considers Medacta Group to be Modestly Undervalued.

Key valuation signals for FRA:6MD:

  • Forward Dividend Yield %: 0.85%
  • GF Value™: €178.79 vs. price of €143.00 (20% below fair value)
  • GF Score™: 91/100 with 2 warning signs
  • Industry Position: 58.4% below the Medical Devices & Instruments median (#257 of 316)

No single metric tells the full story. See the FRA:6MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medacta Group Business Description

Address Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
91GF Score

Get the complete analysis for FRA:6MD

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.00
Price
€178.79
GF Value